Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Clinical trial NCT04375384 · RECRUITING

Trial details

NCT number: NCT04375384
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma Metastatic Head-and-neck Squamous-cell Carcinoma

Start date: 2020-07-01
Primary completion: 2026-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.